Annual Cash & Cash Equivalents
$35.97 M
-$35.34 M-49.56%
December 31, 2023
Summary
- As of February 7, 2025, ANAB annual cash & cash equivalents is $35.97 million, with the most recent change of -$35.34 million (-49.56%) on December 31, 2023.
- During the last 3 years, ANAB annual cash & cash equivalents has fallen by -$214.49 million (-85.64%).
- ANAB annual cash & cash equivalents is now -92.75% below its all-time high of $495.73 million, reached on December 31, 2021.
Performance
ANAB Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$191.58 M
+$119.76 M+166.75%
September 1, 2024
Summary
- As of February 7, 2025, ANAB quarterly cash and cash equivalents is $191.58 million, with the most recent change of +$119.76 million (+166.75%) on September 1, 2024.
- Over the past year, ANAB quarterly cash and cash equivalents has increased by +$137.89 million (+256.79%).
- ANAB quarterly cash and cash equivalents is now -61.35% below its all-time high of $495.73 million, reached on December 31, 2021.
Performance
ANAB Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ANAB Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -49.6% | +256.8% |
| 3 y3 years | -85.6% | -43.0% |
| 5 y5 years | -68.3% | +4.8% |
ANAB Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.8% | at low | -61.4% | +628.6% |
| 5 y | 5-year | -92.8% | at low | -61.4% | +628.6% |
| alltime | all time | -92.8% | +1179.9% | -61.4% | +1034.0% |
AnaptysBio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $191.58 M(+166.7%) |
| Jun 2024 | - | $71.82 M(+33.8%) |
| Mar 2024 | - | $53.70 M(+49.3%) |
| Dec 2023 | $35.97 M(-49.6%) | $35.97 M(+36.8%) |
| Sep 2023 | - | $26.30 M(-25.3%) |
| Jun 2023 | - | $35.21 M(-62.8%) |
| Mar 2023 | - | $94.56 M(+32.6%) |
| Dec 2022 | $71.31 M(-85.6%) | $71.31 M(+21.8%) |
| Sep 2022 | - | $58.55 M(-18.3%) |
| Jun 2022 | - | $71.70 M(-56.9%) |
| Mar 2022 | - | $166.41 M(-66.4%) |
| Dec 2021 | $495.73 M(+97.9%) | $495.73 M(+47.4%) |
| Sep 2021 | - | $336.33 M(+1.2%) |
| Jun 2021 | - | $332.25 M(+16.9%) |
| Mar 2021 | - | $284.15 M(+13.5%) |
| Dec 2020 | $250.46 M(+46.5%) | $250.46 M(+19.7%) |
| Sep 2020 | - | $209.15 M(-5.4%) |
| Jun 2020 | - | $221.17 M(+33.8%) |
| Mar 2020 | - | $165.32 M(-3.3%) |
| Dec 2019 | $171.02 M | $171.02 M(-6.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $182.90 M(+24.8%) |
| Jun 2019 | - | $146.55 M(+38.4%) |
| Mar 2019 | - | $105.85 M(-6.8%) |
| Dec 2018 | $113.60 M(+39.9%) | $113.60 M(-61.3%) |
| Sep 2018 | - | $293.41 M(+414.2%) |
| Jun 2018 | - | $57.06 M(-17.9%) |
| Mar 2018 | - | $69.47 M(-14.4%) |
| Dec 2017 | $81.19 M(+58.5%) | $81.19 M(+204.4%) |
| Sep 2017 | - | $26.67 M(-13.3%) |
| Jun 2017 | - | $30.75 M(-68.2%) |
| Mar 2017 | - | $96.75 M(+88.9%) |
| Dec 2016 | $51.23 M(-0.9%) | $51.23 M(+8.7%) |
| Sep 2016 | - | $47.13 M(-6.8%) |
| Jun 2016 | - | $50.59 M(+2.6%) |
| Mar 2016 | - | $49.32 M(-4.6%) |
| Dec 2015 | $51.68 M(+132.9%) | $51.68 M(-6.4%) |
| Sep 2015 | - | $55.24 M(+227.0%) |
| Jun 2015 | - | $16.89 M(-23.9%) |
| Dec 2014 | $22.19 M(+689.6%) | $22.19 M |
| Dec 2013 | $2.81 M | - |
FAQ
- What is AnaptysBio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for AnaptysBio?
- What is AnaptysBio annual cash & cash equivalents year-on-year change?
- What is AnaptysBio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for AnaptysBio?
- What is AnaptysBio quarterly cash and cash equivalents year-on-year change?
What is AnaptysBio annual cash & cash equivalents?
The current annual cash & cash equivalents of ANAB is $35.97 M
What is the all time high annual cash & cash equivalents for AnaptysBio?
AnaptysBio all-time high annual cash & cash equivalents is $495.73 M
What is AnaptysBio annual cash & cash equivalents year-on-year change?
Over the past year, ANAB annual cash & cash equivalents has changed by -$35.34 M (-49.56%)
What is AnaptysBio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ANAB is $191.58 M
What is the all time high quarterly cash and cash equivalents for AnaptysBio?
AnaptysBio all-time high quarterly cash and cash equivalents is $495.73 M
What is AnaptysBio quarterly cash and cash equivalents year-on-year change?
Over the past year, ANAB quarterly cash and cash equivalents has changed by +$137.89 M (+256.79%)